Skip to main content
. 2022 Mar 22;12:842312. doi: 10.3389/fonc.2022.842312

Figure 6.

Figure 6

Sox15 inhibits in vivo HCC tumorigenicity. (A) The overexpression efficiency of Sox15 within the HCC cells as measured through the WB assay. (B) The tumor growth curve in nude mice. (C, D) The typical image and tumor weight of Sox15-transfected and vector-transfected tumors at the time of sacrifice. (E, F) Classic HE and Ki67 IHC of tumor samples and quantification. *p < 0.05.